0002002988-23-000002.txt : 20231205 0002002988-23-000002.hdr.sgml : 20231205 20231205164922 ACCESSION NUMBER: 0002002988-23-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231205 DATE AS OF CHANGE: 20231205 EFFECTIVENESS DATE: 20231205 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Retension Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0002002988 IRS NUMBER: 932592788 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-498860 FILM NUMBER: 231467285 BUSINESS ADDRESS: STREET 1: C/O REDUX THERAPEUTICS, LLC STREET 2: 902 TURKEY RUN ROAD CITY: MCLEAN STATE: VA ZIP: 22101 BUSINESS PHONE: (703) 624-2024 MAIL ADDRESS: STREET 1: C/O REDUX THERAPEUTICS, LLC STREET 2: 902 TURKEY RUN ROAD CITY: MCLEAN STATE: VA ZIP: 22101 D 1 primary_doc.xml X0708 D LIVE 0002002988 Retension Pharmaceuticals, Inc. C/O REDUX THERAPEUTICS, LLC 902 TURKEY RUN ROAD MCLEAN VA VIRGINIA 22101 (703) 624-2024 DELAWARE None None Corporation true 2023 Eric Keller c/o Redux Therapeutics, LLC 902 Turkey Run Road McLean VA VIRGINIA 22101 Executive Officer Director Michael Berendt c/o Redux Therapeutics, LLC 902 Turkey Run Road McLean VA VIRGINIA 22101 Director Donald Olds c/o Redux Therapeutics, LLC 902 Turkey Run Road McLean VA VIRGINIA 22101 Director Pharmaceuticals Decline to Disclose 06b false 2023-11-21 false true false 0 Collage Venture Partners, LLC 316063 None None 929 Alton Road Suite 500 Miami Beach FL FLORIDA 33139 AL ALABAMA AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT FL FLORIDA GA GEORGIA IL ILLINOIS IN INDIANA KS KANSAS MD MARYLAND MA MASSACHUSETTS MI MICHIGAN MN MINNESOTA MO MISSOURI NV NEVADA NJ NEW JERSEY NM NEW MEXICO NY NEW YORK NC NORTH CAROLINA OH OHIO PA PENNSYLVANIA TN TENNESSEE TX TEXAS UT UTAH VA VIRGINIA WA WASHINGTON WI WISCONSIN false Stonehaven, LLC 118913 None None 275 Madison Avenue Suite 2002 New York NY NEW YORK 10016 All States false 8000000 5819900 2180100 false 82 413955 true 0 true 0 true false Retension Pharmaceuticals, Inc. /s/Eric Keller Eric Keller President 2023-12-05